Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ostronoff

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 18, 2006
Multidrug-resistant Pseudomonas aeruginosa infection in neutropenic patients successfully treated with a combination of polymyxin B and rifampinM Ostronoff, F Ostronoff, A Sucupira, et al.
Bone Marrow Transplantation|January 1, 1991
Lack of correlation between serum levels and receptor expression of TNF alpha and graft versus host disease following allogeneic bone marrow transplantationE Robinet, J L Pico, A Ibrahim, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
High-dose chemotherapy with etoposide, cyclophosphamide and escalating dose of carboplatin followed by autologous bone marrow transplantation in cancer patients. A pilot studyA Ibrahim, E Zambon, J H Bourhis, et al.
Progress in Clinical and Biological Research|January 1, 1989
Phase II trial with etoposide (VP16) plus ifosfamide plus high-dose cisplatin (VIhP regimen) in refractory germ cell tumorsJ P Droz, V Ribrag, M Ghosn, et al.
Leukemia & Lymphoma|August 5, 2006
Safety of fractionated dose of rituximab in renal failure patients receiving hemodialysisF Ostronoff, M Ostronoff, R Florêncio, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1992
Burkitt's lymphoma in adults: a retrospective study of 46 casesM Ostronoff, C Soussain, E Zambon, et al.
Bulletin Du Cancer|January 1, 1990
[Value of high-dose chemotherapy followed by bone marrow autograft in non-seminomatous germinal tumor with poor prognosis. Results of the combination of cisplatinum, etoposide and cyclophosphamide (PEC protocol)]D Baume, J L Pico, J P Droz, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 1994
Super-high-risk germ-cell tumors: a clinical entity. Report of eleven casesA Moran-Ribon, J P Droz, J Kattan, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Long-term survivors after salvage high dose chemotherapy with bone marrow rescue in refractory germ cell cancerJ P Droz, J L Pico, M Ghosn, et al.
Cancer|July 1, 1988
Salvage chemotherapy in refractory germ cell tumors with etoposide (VP-16) plus ifosfamide plus high-dose cisplatin. A VIhP regimenM Ghosn, J P Droz, C Theodore, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 18, 2006
Multidrug-resistant Pseudomonas aeruginosa infection in neutropenic patients successfully treated with a combination of polymyxin B and rifampinM Ostronoff, F Ostronoff, A Sucupira, et al.
Bone Marrow Transplantation|January 1, 1991
Lack of correlation between serum levels and receptor expression of TNF alpha and graft versus host disease following allogeneic bone marrow transplantationE Robinet, J L Pico, A Ibrahim, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
High-dose chemotherapy with etoposide, cyclophosphamide and escalating dose of carboplatin followed by autologous bone marrow transplantation in cancer patients. A pilot studyA Ibrahim, E Zambon, J H Bourhis, et al.
Progress in Clinical and Biological Research|January 1, 1989
Phase II trial with etoposide (VP16) plus ifosfamide plus high-dose cisplatin (VIhP regimen) in refractory germ cell tumorsJ P Droz, V Ribrag, M Ghosn, et al.
Leukemia & Lymphoma|August 5, 2006
Safety of fractionated dose of rituximab in renal failure patients receiving hemodialysisF Ostronoff, M Ostronoff, R Florêncio, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1992
Burkitt's lymphoma in adults: a retrospective study of 46 casesM Ostronoff, C Soussain, E Zambon, et al.
Bulletin Du Cancer|January 1, 1990
[Value of high-dose chemotherapy followed by bone marrow autograft in non-seminomatous germinal tumor with poor prognosis. Results of the combination of cisplatinum, etoposide and cyclophosphamide (PEC protocol)]D Baume, J L Pico, J P Droz, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 1994
Super-high-risk germ-cell tumors: a clinical entity. Report of eleven casesA Moran-Ribon, J P Droz, J Kattan, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Long-term survivors after salvage high dose chemotherapy with bone marrow rescue in refractory germ cell cancerJ P Droz, J L Pico, M Ghosn, et al.
Cancer|July 1, 1988
Salvage chemotherapy in refractory germ cell tumors with etoposide (VP-16) plus ifosfamide plus high-dose cisplatin. A VIhP regimenM Ghosn, J P Droz, C Theodore, et al.
Pageof 4